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44 The Journal of Thoracic and Cardiobjective: The mechanism of spinal cord injury is believed to be related to the
ulnerability of spinal motor neuron cells to ischemia. The aim of this study was to
nvestigate whether ONO-5046, a specific inhibitor of neutrophil elastase that can
ttenuate tissue or organ injury in various pathologic conditions, could protect
gainst ischemic spinal cord damage.
ethods: After induction of spinal ischemia, ONO-5046 or vehicle was injected
ntravenously. Cell damage was analyzed by counting the number of motor neurons.
o investigate the mechanism by which ONO-5046 prevents ischemic spinal cord
amage, we observed the immunoreactivity of CPP32 (caspase3), brain-derived
eurotrophic factor, and phosphorylated extracellular signal–regulated kinase.
esults: ONO-5046 eased the functional deficits and increased the number of motor
eurons after ischemia. The induction of caspase3 was significantly reduced by
NO-5046 treatment. Furthermore, the expressions of brain-derived neurotrophic
actor and phosphorylated extracellular signal–regulated kinase were prolonged.
onclusion: ONO-5046 may protect motor neurons from ischemic injury by reduc-
ng caspase3 and prolonging the expressions of brain-derived neurotrophic factor
nd phosphorylated extracellular signal–regulated kinase. ONO-5046 may be a
trong candidate for use as a therapeutic agent in the treatment of ischemic spinal
ord injury.
pinal cord injury after a successful operation on the thoracic aorta is a
disastrous and unpredictable complication in human beings. In an attempt to
prevent this complication, various methods of spinal cord protection have
een suggested, including temporary shunts, partial bypass, and systemic or regional
ypothermia. Regardless of the surgical technique or method of spinal cord protec-
ion used,1 however, none of the methods developed to date can totally protect
gainst the possible development of paraplegia. The reported prevalence of para-
legia ranges from 2.3% to 23% for operations on the thoracic aorta.2 The mech-
nism of spinal cord injury during operations on the thoracic aorta is believed to be
rimarily related to direct tissue ischemia. Ischemia can occur when there is
vascular Surgery ● March 2006
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Permanent exclusion of the essential intercostal arterial
lood supply to the spinal cord or temporary interruption of
he spinal cord blood flow.3 For a rabbit spinal cord isch-
mia model, we have previously reported delayed and se-
ective motor neuron death after transient ischemia, which
as strongly associated with activated apoptotic signals of
he caspase3 cascade.4
It has been demonstrated that there is significant upregu-
ation of brain-derived growth factor (BDNF) in peri-isch-
mic regions after a noninjurious interval of middle cerebral
rtery occlusion in the rat.5 Furthermore, increased expres-
ion of BDNF evoked by spreading cortical depression has
een shown to be correlated with induced tolerance against
therwise injurious intervals of cerebral ischemia in the rat.6
he extracellular signal–regulated kinase (ERK) signaling
athways are primary mediators of axonal growth and neu-
onal survival.7,8 ERK 1/2 has been reported to be activated
y BDNF in cortical,9 hippocampal,10 and motor neurons.11
n the basis of these studies, ERK 1/2 is considered to be a
seful marker and survival intracellular signal transduction of
eurotrophic activation by BDNF.
Recently it has been shown that activated neutrophils play
central role in the development of ischemia-reperfusion–
nduced central nerve injury.12 Activated neutrophils may pro-
uce cerebral damage by means of free radicals, elastase, and
ytokines. Furthermore, it has been reported that inhibi-
ion of neutrophil elastase decreases cytokine-induced neutro-
hil chemoattractants and that neutrophil elastase stimulates
ntercellular adhesion molecule 1 expression.13 ONO-5046,
-(2-[4-{2,2-dimethylpropionyloxy}phenylsulfonylamino]ben-
oyl)aminoacetate tetrahydrate, is a potent, specific, and
ntravenously active neutrophil elastase inhibitor.14 ONO-
046 can attenuate tissue or organ injury in various patho-
ogic conditions by specifically inhibiting neutrophil elas-
ase.15 However, the possibility that ONO-5046 may be
ffective for protecting motor neurons in the spinal cord
rom ischemic injury has not yet been examined. In this
tudy, we investigated the protective effects of ONO-5046
fter transient spinal cord ischemia and found that it reduced
he apoptotic signaling of caspase3, prolonged the presence
f the cell survival signals of phosphorylated ERK (p-ERK)
nd BDNF, and protected spinal cord motor neurons from
Abbreviations and Acronyms
BDNF  brain-derived neurotrophic factor
ERK  extracellular signal–regulated kinase
MEK mitogen-activated protein kinase/ERK kinase
p-ERK phosphorylated extracellular signal–regulated
kinaseschemic injury. t
The Journal of Thoracicaterials and Methods
aterials
-(2-[4-{2,2-dimethylpropionyloxy}phenylsulfonylamino]benzoyl)
minoacetate tetrahydrate (ONO-5046) was kindly provided by Ono
harmaceutical Company (Osaka, Japan).
nimal Models
hirty-three male domesticated white rabbits (Kitayama Rabess
ompany, Nagano, Japan), weighing 2.5 to 3 kg, were divided into
hree groups: sham operation control group (sham group), transient
schemia and treatment with vehicle group (group I), and transient
schemia and treatment with ONO-5046 group (10 mg/[kg · h],
roup O). All rabbits were allowed free access to food and water
efore and after the procedure, and were treated in accordance with
he Declaration of Helsinki and the “Guide for the Care and Use
f Laboratory Animals” (http://www.nap.edu/catalog/5140.html).
he experimental and animal care protocols were approved by
he Animal Care Committee of the Osaka University School of
edicine.
Anesthesia was induced by intramuscular administration of
etamine at a dose of 50 mg/kg and maintained with 2% halothane
n oxygen by inhalation. A 5F pediatric balloon-tipped catheter
model 405; Braun, Melsungen, Germany) was inserted through
he right femoral artery and advanced 15 cm forward into the
bdominal aorta. Preliminary experiments had already confirmed
hat the balloon in the distal end of the catheter should be posi-
ioned 0.5 to 1.5 cm distal to the left renal artery.16 The catheter
as immediately removed without injection or balloon inflation in
he sham group. In groups I and O, spinal cord ischemia was
chieved by inflating the balloon to obstruct blood flow to the
pinal cord. Our previous experiments confirmed that 15 minutes
f transient spinal cord ischemia was sufficient for selective and
elayed motor neuron death.17 Saline solution (vehicle, 1 mL/kg
ody weight) or ONO-5046 (5 mg/mL in saline vehicle) was
dministered intravenously from the induction of ischemia until 60
inutes of reperfusion. Immediately after death, the spinal cord
as quickly removed with the plunger of a 1-mL syringe.18 All
amples were frozen in powdered dry ice and stored at 80°C
ntil use. The spinal cords were then cut transversely at approxi-
ately the L2 or L3 level and mounted on glass slides.
eurologic Assessment
eurologic function was assessed before the rabbits were killed at
days after reperfusion (n  5 for each group). The rabbits were
lassified according to a 5-point scale devised by Johnson and
olleagues19 as follows: 0, hind-limb paralysis; 1, severe parapa-
esis; 2, functional movement, no hop; 3, ataxia, uncoordinated
op; 4, minimal ataxia; and 5, normal function. Two individuals
ithout knowledge of the treatment independently graded the
eurologic function. The Mann-Whitney U test was used to com-
are the neurologic scores and cell numbers.
istologic Study
ections taken at 7 days after reperfusion in all groups were
tained with hematoxylin-eosin and examined under light micros-
opy. An observer who was unaware of the animal group or
eurologic outcome examined each slide. With hematoxylin-eosin,
he cells were considered dead if the cytoplasm was diffusely
and Cardiovascular Surgery ● Volume 131, Number 3 645
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CSPosinophilic and viable if the cells showed basophilic stripping
contained Nissl substance). The Mann-Whitney U test was used to
ompare the neurological scores and cell numbers.
DNF, p-ERK, and Caspase3 Immunocytochemical
xamination
e also performed an immunohistochemical study to investigate
hanges in the expressions of BDNF, p-ERK, and caspase3 at 8
ours, 1 day, and 2 days after reperfusion in groups I and O and at
days in the sham group (n  3 each). Spinal cord sections were
insed in 0.1 mol/L phosphate-buffered saline solution for 20
inutes and blocked in 2% normal horse serum for 2 hours at
oom temperature. Next, they were incubated with a primary
ntibody diluted 1:200 in 10% normal horse or rabbit serum and
.3% Triton X-100 (The Dow Chemical Company, Midland,
ich) for 20 hours at 4°C. The primary antibodies used were as
ollows: sheep polyclonal anti-BDNF antibody (AB1513p;
HEMICON International Inc, Temecula, Calif), mouse poly-
lonal anti-ERK phosphospecific (SC-7383; Santa Cruz Biotech-
ology, Inc, Santa Cruz, Calif), and mouse monoclonal
nticaspase3 p20 (SC-1226; Santa Cruz Biotechnology) antibod-
es. After quenching of the endogenous peroxidase activity by
ncubation in 0.3% hydrogen peroxide and 10% methanol for 20
inutes, the slides were washed in phosphate-buffered saline
olution and incubated for 3 hours with biotinylated anti–sheep
gG (PK-6106; Vector Laboratories, Inc, Burlingame, Calif), bio-
inylated anti–mouse IgG (PK-6102; Vector Laboratories), or bio-
inylated anti–goat IgG (PK-6105; Vector Laboratories) diluted 1:200
n phosphate-buffered saline solution containing 0.018% normal
orse or rabbit serum. Next, the slides were incubated with avidin–
iotin–horseradish peroxidase complex (PK-6102; Vector Labora-
ories), followed by color development of the positive staining
ith 3,3=-diamino-benzidine and hydrogen peroxide solution and
ounterstaining of the cytoplasm with hematoxylin-eosin. Another
et of sections were stained in a similar way but without the
rimary antibody to ascertain the specific binding of each antibody
o its target protein.
esults
eurologic Assessment
he neurologic results are summarized in Table 1. All the
abbits survived until the end of the observation period. All
ham-operated control animals (n  5) demonstrated nor-
ABLE 1. Neurologic functional scores on day 7 after the
rocedure
nimal Sham Group I Group O
5 3 5
5 2 5
5 2 5
5 2 3
5 4 4
ean SD 5 2.6  0.90 4.4  0.90*
P  .013 versus group I.al neurologic function (score of 5). Until 2 days after fi
46 The Journal of Thoracic and Cardiovascular Surgery ● Marceperfusion, neurologic function was preserved, and there
as no significant difference between groups I and O (data
ot shown). Almost all the rabbits in group I demonstrated
evere paraparesis by 7 days (n  5). In group O, the
eterioration of neurologic function was eased significantly
elative to that in group I (P  .013).
istologic Study
he numbers of intact motor neurons are summarized in
able 2. In sham-operated control animals, the spinal cord
as intact with many large motor neurons in the anterior
orn (Figure 1, A). Seven days after blood flow restoration
n group I, however, about 60% of the motor neurons in the
pinal cord were damaged (Figure 1, B). Seven days after
eperfusion in group O (Figure 1, D), there was less evi-
ence of damaged motor neurons. The number of intact
otor neurons in group O was significantly larger than that
n group I (P  .0028; Table 2).
mmunohistochemical Study
able 3 shows a summary of the immunohistochemical
nalysis for each group. The spinal cords of sham-operated
nimals showed slight immunoreactivity for BDNF (Figure
, A) but did not contain p-ERK (Figure 3, A) or caspase3
Figure 4, A) immunoreactivity. After 15 minutes of tran-
ient ischemia, BDNF (Figure 2, B), p-ERK (Figure 3, B),
nd caspase3 (Figure 4, B) were induced in motor neurons
fter 8 hours of reperfusion but had almost disappeared at 1
ay (Figure 2, C, Figure 3, C, and Figure 4, C, respectively).
n group O, immunoreactivity for caspase3 was not ob-
erved (Figure 4, E, F, and G). Relative to group I, motor
eurons showed prolonged immunoreactivity for BDNF
Figure 2, E and F) and p-ERK. (Figure 3, E and F) at 8
ours and 1 day after reperfusion and then started to weaken
t 2 days (Figure 2, G, Figure 3, G).
iscussion
ctivated neutrophils have been reported to contribute to
schemia-reperfusion injury in the brain and spinal cord.12
ctivated neutrophils may forward tissue damage through
ree radicals, elastase, and cytokines. Neutrophil elastase is
n enzyme capable of damaging endothelial cells.20 It also
egrades extracellular matrix components, including elastin,
ABLE 2. Number of large motor neurons in the ventral
ray matter on day 7 after the procedure
Animal group No. of cells
Sham 19.0 1.0
Group I 7.8 3.1
Group 0 16.8 3.4*
P  .0028 versus group I.bronectin, proteoglycans, and collagen. The extracellular
h 2006
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Patrix components of the endothelial basement membrane
ave a key function as a vascular barrier that limits fluid and
olute exchange and may also restrict granulocyte extrava-
ation.21 Neutrophil elastase increases vascular permeability
nd damages endothelial integrity.22 The endothelial dam-
ge also induces microcirculatory disturbance, leading to
issue ischemia and cellular damge.21
ONO-5046 is a new, specific, and reversible inhibitor of
uman neutrophil elastase that has shown beneficial effects
n various tissue injuries.15,20 ONO-5046 has been reported
igure 1. Histologic findings of spinal cord 7 days after 15 min-
tes of ischemia (hematoxylin-eosin staining). A, Sham-operated
ontrol spinal cord is intact. B, In spinal cord of group I (15
inutes of ischemia), about 60% of motor neurons are lost. C, In
roup O, there is less evidence of damaged motor neurons, and no
lial changes are found. Bar represents 200 m.o prevent neutrophil accumulation and reduce cerebral o
The Journal of Thoracicschemic damage in middle cerebral artery occlusion in a rat
odel.23 However, the effects of this elastase inhibitor on
eurologic function and intracellular signal transduction
fter transient ischemia in the spinal cord and brain have
een unclear. We therefore investigated whether ONO-5046
ad a preventive effect in the anterior horn of the spinal cord
fter transient ischemia. Treatment with ONO-5046 resulted
n protection against paraplegia and demonstrated a protec-
ive effect on motor neurons. It also prevented the induction
f caspase3 (CPP32) and prolonged the expressions of
DNF and p-ERK in motor neurons.
Caspase3 is a member of the interleukin-converting
nzyme-like proteases, which are related to mammalian
poptosis and inflammation.24 Our previous study demon-
trated that an increase in the immunoreactivity of the
poptosis-inducing protein caspase3 occurred in the motor
euron cells of the spinal cord after 15 minutes of transient
schemia and that the peak of caspase3 induction preceded
NA fragmentation in the spinal cord after the ischemic
nsult.4 These findings suggest that overexpression of caspase3
ay play an important role in the induction of DNA fragmen-
ation in the spinal cord. The expression of caspase3 preceded
he appearance of neuronal damage and may therefore have
een involved in the activation of apoptosis.
BDNF is one of the neurotrophic factors and acts through
pecific receptors on neurons to effect biologic activities
uch as neuronal survival, stimulation of neurite outgrowth,
nd activation of neurotransmitter synthesis and release.
he action of BDNF on motor neurons has been extensively
tudied in injury models and spontaneous motor nerve de-
eneration models. An active and potentially protective role
or BDNF in inducing higher resistance of cerebral and
pinal neurons against ischemia is further supported by the
ABLE 3. Summary of immunohistochemical analysis for
ach group (n  3)
8 h 1 d 2 d
DNF
Sham   
Group I         
Group O    2 2 2   
-ERK
Sham ! ! !
Group I 2 2 2  ! ! ! ! !
Group O 2 2 2 2 2 2   
aspase3
Sham ! ! !
Group I 2 2    ! ! ! !
Group O ! ! ! ! ! ! ! ! !
, Negative; , subtly positive reaction; , positive reaction; 2, strongly
nhanced reaction.bservation that intracerebroventricular BDNF infusion
and Cardiovascular Surgery ● Volume 131, Number 3 647
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CSP
rovides significant protection to CA1 hippocampal neurons
fter global cerebral ischemia in the rat.25
The ERKs, downstream signal components of BDNF,
egulate a diverse array of functions, such as cell growth and
roliferation, differentiation, and apoptosis.26 Phosphoryla-
ion is required for full enzymatic activation. The signifi-
ance of a p-ERK increase for cell survival is somewhat
ncertain, because previous studies have suggested both
ntiapoptotic and proapoptotic roles for p-ERK 1/2.26,27 In
ypoxic neuronal injury with primary cultures from the
urine cerebral cortex, the mitogen-activated protein ki-
ase/ERK kinase (MEK) 1/2 inhibitor PD98059 increased
igure 2. Immunohistochemical staining for BDNF in sham-
perated control spinal cord (A) and in spinal cords at 8 hours (B),
day (C), and 2 days (D) in group I and at 8 hours (E), 1 day (F) and
days (G) in group O. Prolonged BDNF immunoreactivity is
resent in motor neurons of group O (black arrows). Bar repre-
ents 400 m.euronal death in hypoxic cultures, suggesting that MEK t
48 The Journal of Thoracic and Cardiovascular Surgery ● Marc/2 promotes neuronal survival.28 Moreover, PD98059 also
educed phosphoinactivation of Bad in hypoxic cultures,
uggesting that a cell-survival program involving phospho-
ctivation of MEK 1/2 and its downstream ERK 1/2 and
nactivation of Bad is mobilized in hypoxic neurons and may
elp to regulate neuronal fate after hypoxic-ischemic injury.
In the neonatal brain, BDNF is markedly neuroprotective
gainst neonatal hypoxic-ischemic brain injury in vivo.29
ntracerebroventricular administration of BDNF to rats on
ostnatal day 7 resulted in phosphorylation of ERK 1/2.
harmacologic inhibition of ERK inhibited the ability of
DNF to block hypoxic-ischemic caspase3 activation and
igure 3. Immunohistochemical staining for p-ERK in sham-
perated control spinal cord (A) and in spinal cords at 8 hours (B),
day (C), and 2 days (D) in group I and at 8 hours (E), 1 day (F), and
days (G) in group O. Prolonged p-ERK immunoreactivity is
resent in nuclei of motor neurons in group O (black arrows). Bar
epresents 400 m.issue loss. These results suggest that p-ERK may be in-
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Polved in cell survival signaling in central nerves after
schemia. In our study, BDNF and p-ERK proteins were
xpressed in an early stage of reperfusion in motor neuron
ells of the ventral gray matter. The induction reached a
aximum at 8 hours and almost disappeared at 1 day. It has
een demonstrated that there is significant upregulation of
DNF in peri-ischemic regions after a noninjurious interval
f middle cerebral artery occlusion in the rat.5 We have
reviously reported the induction of glial cell line–derived
eurotrophic factor and c-ret proto-oncogene receptor ty-
osine kinase after transient spinal cord ischemia in the
abbit.16 In a rat model, a transient, noninjurious interval of
igure 4. Immunohistochemical staining for caspase3 in sham-
perated control spinal cord (A) and in spinal cords at 8 hours (B),
day (C), and 2 days (D) in group I and at 8 hours (E), 1 day (F), and
days (G) in group O. Density of caspase3 immunoreactivity in
roup O is reduced relative to that in group I (black arrows). Bar
epresents 400 m.pinal ischemia led to significant increases in spinal glial
The Journal of Thoracicell line–derived neurotrophic factor and BDNF expres-
ions.30 A variety of pathologic insults, including ischemia,
ave been reported to upregulate several growth factors, and
hese can play important roles in modulating the survival of
rain and spinal cord neurons. The prolonged expressions of
DNF and its important signaling component p-ERK there-
ore may be among the factors responsible for easing spinal
ord ischemic damage. However, the exact mechanism of
he prolonged expression of survival cell signals after ONO-
046 treatment remains unclear. We previously demon-
trated that the expression of heat shock protein the spinal
ord was prolonged for local hypothermic ischemia relative
o normothermic ischemia.17 One possible hypothesis for
his is as follows: transient ischemia induces the stress
esponse of motor neurons, such as induction of some
rowth factors and stress response proteins, and motor neu-
ons less damaged as a result of possibly beneficial treat-
ents (such as hypothermia or medicines) may have the
bility to prolong the production of these proteins relative to
eurons without such treatments.
The mechanism of neutrophil-mediated spinal cord isch-
mia injury is not fully understood, especially with regard to
ntracellular cell signal transduction. Inhibition of neutro-
hil elastase by ONO-5046 may ease ischemic motor dam-
ge by prolonging the expression of survival signal trans-
uction molecules, including BDNF and p-ERK, and
uppressing the expression of the death signal transduction
olecule caspase3. A balance between cell survival signals
such as BDNF and p-ERK) and death signals (such as
ctivated caspase3) may be important for determining the
ell fate of survival or death under both normal and patho-
ogic conditions. Neutrophils may affect the survival and
eath-promoting events in spinal cord ischemic injury.
This study has revealed that ONO-5046 can protect the
otor neurons of the spinal cord from ischemic injury.
nhibition of neutrophil elastase reduces the induction of
aspase3 and prolongs the expression of BDNF and p-ERK.
n the near future, ONO-5046 should therefore be a strong
andidate for use as a therapeutic agent in the treatment of
schemic spinal cord injury.
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